ATLANTA, May 3, 2023 /PRNewswire/ -- Resilia Pharmaceuticals, Inc. announced today that it has brought Neosalus® Cream and Neosalus® Lotion back to the market. Neosalus® Lotion is a non-steroidal anti-inflammatory prescription product that offers topical treatment for the management of skin disorders, including atopic dermatitis and allergic contact dermatitis. These products had not been available due to supply chain disruptions that occurred as a result of the COVID-19 public health crisis.
ATLANTA, April 19, 2023 /PRNewswire/ -- Resilia Pharmaceuticals, Inc. announced today that it has re-launched Solace® Eczema Cream on Amazon® and restored the supply of this product that had formerly only been available by prescription. Solace is marketed under Resilia's Santefirm Consumer Healthcare, Inc.™ label.